BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34026601)

  • 1. Distinct Genomic Landscape of Colorectal Mucinous Carcinoma Determined
    Huang L; Luo S; Zhang X; Cai Y; Xue F; Hu H; Zeng Z; Lin T; Wang F; Wang W; Zhang S; Kang L
    Front Oncol; 2021; 11():603564. PubMed ID: 34026601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
    Kim H; Kim BH; Lee D; Shin E
    Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
    BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Characteristics and Mutation Spectrum of Colorectal Adenocarcinoma With Mucinous Component in a Chinese Cohort: Comparison With Classical Adenocarcinoma.
    Chen J; Zhou L; Gao J; Lu T; Wang J; Wu H; Liang Z
    Front Oncol; 2020; 10():917. PubMed ID: 32582557
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinicopathological and genetic differences between low-grade and high-grade colorectal mucinous adenocarcinomas.
    Yoshioka Y; Togashi Y; Chikugo T; Kogita A; Taguri M; Terashima M; Mizukami T; Hayashi H; Sakai K; de Velasco MA; Tomida S; Fujita Y; Tokoro T; Ito A; Okuno K; Nishio K
    Cancer; 2015 Dec; 121(24):4359-68. PubMed ID: 26488212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Genetic Features of Primary Nonurachal Enteric-type Adenocarcinoma, Urachal Adenocarcinoma, Mucinous Adenocarcinoma, and Intestinal Metaplasia/Adenoma: Review of the Literature and Next-generation Sequencing Study.
    Pires-Luis AS; Martinek P; Alaghehbandan R; Trpkov K; Comperat EM; Perez Montiel DM; Bulimbasic S; Lobo J; Henrique R; Vanecek T; Pivovarcikova K; Michalova K; Pitra T; Hora M; Marques A; Lopes JM; Rogala J; Mareckova J; Michal M; Hes O
    Adv Anat Pathol; 2020 Sep; 27(5):303-310. PubMed ID: 32520749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucinous Histology,
    Harpaz N; Gatt YE; Granit RZ; Fruchtman H; Hubert A; Grinshpun A
    J Oncol; 2020; 2020():6421205. PubMed ID: 32377194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of colorectal mucinous adenocarcinoma and adenocarcinoma, not otherwise specified, identified by multiomic data analysis.
    Xu K; Zheng S; Li B; Shao Y; Yin X
    Front Mol Biosci; 2023; 10():1150362. PubMed ID: 37091868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular background of mucinous carcinoma beyond MUC2.
    Hugen N; Simons M; Halilović A; van der Post RS; Bogers AJ; Marijnissen-van Zanten MA; de Wilt JH; Nagtegaal ID
    J Pathol Clin Res; 2015 Jan; 1(1):3-17. PubMed ID: 27499889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF V600E Mutations in Endometrial Adenocarcinoma.
    He M; Breese V; Hang S; Zhang C; Xiong J; Jackson C
    Diagn Mol Pathol; 2013 Mar; 22(1):35-40. PubMed ID: 23370429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer.
    Mekenkamp LJ; Heesterbeek KJ; Koopman M; Tol J; Teerenstra S; Venderbosch S; Punt CJ; Nagtegaal ID
    Eur J Cancer; 2012 Mar; 48(4):501-9. PubMed ID: 22226571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular spectrum of
    Al-Shamsi HO; Jones J; Fahmawi Y; Dahbour I; Tabash A; Abdel-Wahab R; Abousamra AO; Shaw KR; Xiao L; Hassan MM; Kipp BR; Kopetz S; Soliman AS; McWilliams RR; Wolff RA
    J Gastrointest Oncol; 2016 Dec; 7(6):882-902. PubMed ID: 28078112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component.
    Li X; Sun K; Liao X; Gao H; Zhu H; Xu R
    BMC Cancer; 2020 May; 20(1):400. PubMed ID: 32384877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced rate of copy number aberrations in mucinous colorectal carcinoma.
    Hugen N; Simmer F; Mekenkamp LJ; Koopman M; van den Broek E; de Wilt JH; Punt CJ; Ylstra B; Meijer GA; Nagtegaal ID
    Oncotarget; 2015 Sep; 6(28):25715-25. PubMed ID: 26329972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically advanced and metastatic pure mucinous carcinoma of the breast: a comprehensive genomic profiling study.
    Ross JS; Gay LM; Nozad S; Wang K; Ali SM; Boguniewicz A; Khaira D; Johnson A; Elvin JA; Vergilio JA; Suh J; Miller VA; Stephens PJ
    Breast Cancer Res Treat; 2016 Jan; 155(2):405-13. PubMed ID: 26762307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of differentially expressed genes between mucinous adenocarcinoma and other adenocarcinoma of colorectal cancer using bioinformatics analysis.
    Zhang X; Zuo J; Wang L; Han J; Feng L; Wang Y; Fan Z
    J Int Med Res; 2020 Aug; 48(8):300060520949036. PubMed ID: 32840168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.
    Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM
    Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
    Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S
    Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype.
    Orlando L; Renne G; Rocca A; Curigliano G; Colleoni M; Severi G; Peruzzotti G; Cinieri S; Viale G; Sanna G; Goldhirsch A
    Ann Oncol; 2005 Jul; 16(7):1094-9. PubMed ID: 15855225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous Carcinoma.
    Hugen N; van de Velde CJ; Bosch SL; Fütterer JJ; Elferink MA; Marijnen CA; Rutten HJ; de Wilt JH; Nagtegaal ID
    Ann Surg Oncol; 2015 Aug; 22(8):2669-76. PubMed ID: 25564178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.